Parallax Volatility Advisers
DMAQR

Parallax Volatility Advisers’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Parallax Volatility Advisers’s Portfolio DMAQR Stock Details DMAQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-124,352
Closed -$43.4K – 2591
2023
Q3 		$43.4K Buy
+124,352
New +$32.7K ﹤0.01% 2027

Other funds holding DMAQR

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
SOA
Sea Otter Advisors Miami, Florida $1.78M AUM 2.28% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Parallax Volatility Advisers's DMAQR Position: Q4 2023 in Review

Parallax Volatility Advisers sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q4 2023, closing a stake of 124,352 shares — an estimated $43.4K sold.

Parallax Volatility Advisers first reported a position in DMAQR in Q3 2023 and held it in 1 quarter. The position peaked at $43.4K in Q3 2023. 24 funds tracked by Wall St. Rank hold DMAQR as of Q4 2023.

  • Parallax Volatility Advisers reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q4 2023 after selling out during the quarter.
  • Parallax Volatility Advisers sold 124,352 Deep Medicine Acquisition Corp. Rights shares in Q4 2023, an estimated $43.4K.
  • Parallax Volatility Advisers first reported a position in Deep Medicine Acquisition Corp. Rights in Q3 2023 and held it in 1 quarter.
  • Parallax Volatility Advisers's Deep Medicine Acquisition Corp. Rights position peaked at $43.4K in Q3 2023.
  • 24 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q4 2023.

Based on Parallax Volatility Advisers's 13F filing for Q4 2023, filed 14 Feb 2024.